Baker's antifol in children with late-stage acute lymphocytic leukemia.
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004351:Drug Resistance; D005493:Folic Acid Antagonists / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy*; D008727:Methotrexate / Q000494:pharmacology; D009061:Mouth Mucosa / Q000187:drug effects; D012867:Skin / Q000187:drug effects; D014227:Triazines / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D014227:Triazines; C012071:triazinate; D008727:Methotrexate